arrowhead pharmaceut

arrowhead pharmaceut

NASDAQ:ARWR
Arrowhead Pharmaceuticals Inc.

Chart

Detailed Quote

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Featured Articles and Interviews
Press Releases

Arrowhead Pharmaceuticals Receives Marketing Authorization in the European Union for REDEMPLO® to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome

Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars

Arrowhead Pharmaceuticals to Participate in Upcoming June 2026 Events

The Conversation (0)